BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2014
View Archived Issues
World Parkinson's Day News: recent pathological insights and repurposing efforts
Read More
ASP-8273 efficiently induces and maintains tumor growth regression in mutant EGFR NSCLC models
Read More
Bristol-Myers Squibb presents first-in-human results for the anti-atherosclerosis agent BMS-962476
Read More
Dana-Farber awarded research grant to study cancer vaccine
Read More
Mutation in HIBCH gene identified in patient with Leigh syndrome
Read More
Novartis presents a novel covalent inhibitor of mutant-selective EGFR for the treatment of NSCLC
Read More
PRX-002 enters phase I for Parkinson's disease
Read More
Alpha-1-acid glycoprotein investigated as a breast cancer biomarker
Read More
Data and safety monitoring board recommends continuation of ixCELL-DCM trial
Read More
Biogen Idec and Sobi report topline results from phase III Eloctate trial
Read More
Investigator-initiated study begins for BL-8040 in chronic myeloid leukemia
Read More
Researchers at Genzyme disclose new GCS inhibitors
Read More
Novel BTK inhibitors presented by Roche
Read More
Scientists at Roche design novel agents for CNS disorders
Read More
Assembly Pharmaceuticals raises funds to advance drugs for HBV
Read More
Bristol-Myers Squibb divulges new Notch signaling inhibitors for cancer
Read More
Tetra Discovery collaborates with Broad Institute's Stanley Center on schizophrenia
Read More
AVEO Oncology and Biodesix partner on development of ficlatuzumab and companion diagnostic test
Read More
APEPTICO reports topline results from phase IIa study of AP-301
Read More
Xencor receives milestone payment under XmAb antibody product agreement
Read More
Ironwood Pharmaceuticals synthesizes novel sGC activators for PAH and other disorders
Read More
Neurolixis receives grant to test NLX-101 in animal models of Rett syndrome
Read More
DNA gyrase inhibitors show activity against M. kansasii
Read More
Pfizer returns Aversion product rights to Acura Pharmaceuticals
Read More
FDA accepts Stemline Therapeutics' IND for phase II trial of SL-701 for GBM
Read More